← Back to Search

Device

Continuous Glucose Monitor for Type 2 Diabetes

N/A

Waitlist Available

Led By Sejal Shah, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 1 year study visit

Awards & highlights

Study Summary

This trial is testing whether or not it is feasible to use continuous glucose monitors (CGMs) in youth with type 2 diabetes, and to collect data on how well they tolerate it and how well it works.

Eligible Conditions

Type 2 Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 1 year study visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 1 year study visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1 year study visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of Participants with sustained CGM use

Secondary outcome measures

Change in PedsQoL3.2 score from baseline

Change in Problem Areas in Diabetes score from baseline

Change in Promis Global Health Scale score from baseline

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Continuous Glucose MonitorExperimental Treatment2 Interventions

All participants will be included in this arm

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Continuous Glucose Monitor

2021

Completed Early Phase 1

~860

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,590 Total Patients Enrolled

Sejal Shah, MDPrincipal InvestigatorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research accommodating geriatric participants?

"The target demographic for this medical study consists of children aged 4 to 19."

Answered by AI

Could you provide information about the enrollment status of this research project?

"According to records on clinicaltrials.gov, this particular medical trial is inactive and no longer recruiting patients. First posted on December 1st 2021, the listing was last updated a year later in October of 2022. While this study is not accepting enrollees presently, there are currently 1443 other trials actively looking for participants."

Answered by AI

Would I meet the criteria to become a participant of this clinical experiment?

"To be eligible for this medical trial, applicants must have a diagnosis of type 2 diabetes Mellitus and fall within the age range of 4 to 19. The research team seeks approximately 30 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study

Sejal Shah 2021. "Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05074667.